Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M McLoughlin

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Proceedings (Baylor University. Medical Center)|October 4, 2005
Adenocarcinoma of the stomach: a reviewJames M McLoughlin
The American Surgeon|July 27, 2016
A Case of Pancreatic Intraductal Tubular Carcinoma: A Rare Entity with Improved PrognosisSneha Bhat, James M McLoughlin, Amila Orucevic
Cancer Control : Journal of the Moffitt Cancer Center|March 2, 2006
Resection of colorectal liver metastases: current perspectivesJames M McLoughlin, Eric H Jensen, Mokenge Malafa
Current Treatment Options in Gastroenterology|September 4, 2004
Neuroendocrine Tumors of the PancreasJames M. McLoughlin, Joseph A. Kuhn, Jeffrey T. Lamont
Cancer Control : Journal of the Moffitt Cancer Center|April 11, 2013
The impact of age on morbidity and mortality following esophagectomy for esophageal cancerJames M McLoughlin, James M Lewis, Kenneth L Meredith
Current Opinion in Oncology|May 25, 2006
Microarrays in gastrointestinal cancer: is personalized prediction of response to chemotherapy at hand?Eric H Jensen, James M McLoughlin, Timothy J Yeatman
Surgical Oncology Clinics of North America|July 4, 2007
Cytoreductive surgery for melanomaJames M McLoughlin, Jonathan S Zager, Vernon K Sondak
Cancer Control : Journal of the Moffitt Cancer Center|July 4, 2008
Treatment options for limited or symptomatic metastatic melanomaJames M McLoughlin, Jonathan S Zager, Vernon K Sondak, et al.
Annals of Surgical Oncology|December 2, 2021
Merkel Cell Polyomavirus Antibody Titer Predicts Recurrence-Free SurvivalAaron J Arroyave, James M Lewis, Miles Landry, et al.
The Breast Journal|January 21, 2015
Is the TNM staging system for breast cancer still relevant in the era of biomarkers and emerging personalized medicine for breast cancer - an institution's 10-year experienceAmila Orucevic, Jason Chen, James M McLoughlin, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Proceedings (Baylor University. Medical Center)|October 4, 2005
Adenocarcinoma of the stomach: a reviewJames M McLoughlin
The American Surgeon|July 27, 2016
A Case of Pancreatic Intraductal Tubular Carcinoma: A Rare Entity with Improved PrognosisSneha Bhat, James M McLoughlin, Amila Orucevic
Cancer Control : Journal of the Moffitt Cancer Center|March 2, 2006
Resection of colorectal liver metastases: current perspectivesJames M McLoughlin, Eric H Jensen, Mokenge Malafa
Current Treatment Options in Gastroenterology|September 4, 2004
Neuroendocrine Tumors of the PancreasJames M. McLoughlin, Joseph A. Kuhn, Jeffrey T. Lamont
Cancer Control : Journal of the Moffitt Cancer Center|April 11, 2013
The impact of age on morbidity and mortality following esophagectomy for esophageal cancerJames M McLoughlin, James M Lewis, Kenneth L Meredith
Current Opinion in Oncology|May 25, 2006
Microarrays in gastrointestinal cancer: is personalized prediction of response to chemotherapy at hand?Eric H Jensen, James M McLoughlin, Timothy J Yeatman
Surgical Oncology Clinics of North America|July 4, 2007
Cytoreductive surgery for melanomaJames M McLoughlin, Jonathan S Zager, Vernon K Sondak
Cancer Control : Journal of the Moffitt Cancer Center|July 4, 2008
Treatment options for limited or symptomatic metastatic melanomaJames M McLoughlin, Jonathan S Zager, Vernon K Sondak, et al.
Annals of Surgical Oncology|December 2, 2021
Merkel Cell Polyomavirus Antibody Titer Predicts Recurrence-Free SurvivalAaron J Arroyave, James M Lewis, Miles Landry, et al.
The Breast Journal|January 21, 2015
Is the TNM staging system for breast cancer still relevant in the era of biomarkers and emerging personalized medicine for breast cancer - an institution's 10-year experienceAmila Orucevic, Jason Chen, James M McLoughlin, et al.
Pageof 4